Another Keytruda-Lenvima ambition is dashed as Merck, Eisai end head and neck cancer trial

Add another failed trial to the list of setbacks for Merck and Eisai’s combination of Keytruda and Lenvima. | Add another failed trial to the list of setbacks for Merck and Eisai’s combination of Keytruda and Lenvima. The companies have decided to shut down a phase 3 study testing the PD-1/TKI…#merck #eisai #keytruda #lenvima #tki
Source: Reuters: Health - Category: Consumer Health News Source Type: news